Literature DB >> 10559350

Experimental infection of rhesus and pig-tailed macaques with macaque rhadinoviruses.

K G Mansfield1, S V Westmoreland, C D DeBakker, S Czajak, A A Lackner, R C Desrosiers.   

Abstract

The recognition of naturally occurring rhadinoviruses in macaque monkeys has spurred interest in their use as models for human infection with Kaposi sarcoma-associated herpesvirus (human herpesvirus 8). Rhesus macaques (Macaca mulatta) and pig-tailed macaques (Macaca nemestrina) were inoculated intravenously with rhadinovirus isolates derived from these species (rhesus rhadinovirus [RRV] and pig-tailed rhadinovirus [PRV]). Nine rhadinovirus antibody-negative and two rhadinovirus antibody-positive monkeys were used for these experimental inoculations. Antibody-negative animals clearly became infected following virus inoculation since they developed persisting antibody responses to virus and virus was isolated from peripheral blood on repeated occasions following inoculation. Viral sequences were also detected by PCR in lymph node, oral mucosa, skin, and peripheral blood mononuclear cells following inoculation. Experimentally infected animals developed peripheral lymphadenopathy which resolved by 12 weeks following inoculation, and these animals have subsequently remained free of disease. No increased pathogenicity was apparent from cross-species infection, i.e., inoculation of rhesus macaques with PRV or of pig-tailed macaques with RRV, whether the animals were antibody positive or negative at the time of virus inoculation. Coinoculation of additional rhesus monkeys with simian immunodeficiency virus (SIV) isolate SIVmac251 and macaque-derived rhadinovirus resulted in an attenuated antibody response to both agents and shorter mean survival compared to SIVmac251-inoculated controls (155.5 days versus 560.1 days; P < 0.019). Coinfected and immunodeficient macaques died of a variety of opportunistic infections characteristic of simian AIDS. PCR analysis of sorted peripheral blood mononuclear cells indicated a preferential tropism of RRV for CD20(+) B lymphocytes. Our results demonstrate persistent infection of macaque monkeys with RRV and PRV following experimental inoculation, but no specific disease was readily apparent from these infections even in the context of concurrent SIV infection.

Entities:  

Mesh:

Year:  1999        PMID: 10559350      PMCID: PMC113087     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma.

Authors:  C Boshoff; D Whitby; T Hatziioannou; C Fisher; J van der Walt; A Hatzakis; R Weiss; T Schulz
Journal:  Lancet       Date:  1995-04-22       Impact factor: 79.321

2.  Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection.

Authors:  P S Moore; Y Chang
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

3.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

4.  Titration and characterization of two rhesus-derived SIVmac challenge stocks.

Authors:  M G Lewis; S Bellah; K McKinnon; J Yalley-Ogunro; P M Zack; W R Elkins; R C Desrosiers; G A Eddy
Journal:  AIDS Res Hum Retroviruses       Date:  1994-02       Impact factor: 2.205

5.  Arteriopathy in macaques infected with simian immunodeficiency virus.

Authors:  L V Chalifoux; M A Simon; D R Pauley; J J MacKey; M S Wyand; D J Ringler
Journal:  Lab Invest       Date:  1992-09       Impact factor: 5.662

6.  Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in non-human immunodeficiency virus-infected patients?

Authors:  A Gessain; A Sudaka; J Brière; N Fouchard; M A Nicola; B Rio; M Arborio; X Troussard; J Audouin; J Diebold; G de Thé
Journal:  Blood       Date:  1996-01-01       Impact factor: 22.113

7.  Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma.

Authors:  S Chuck; R M Grant; E Katongole-Mbidde; M Conant; D Ganem
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

8.  In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences.

Authors:  E Cesarman; P S Moore; P H Rao; G Inghirami; D M Knowles; Y Chang
Journal:  Blood       Date:  1995-10-01       Impact factor: 22.113

9.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

Authors:  J Soulier; L Grollet; E Oksenhendler; P Cacoub; D Cazals-Hatem; P Babinet; M F d'Agay; J P Clauvel; M Raphael; L Degos
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

10.  Mycobacterium avium complex in macaques with AIDS is associated with a specific strain of simian immunodeficiency virus and prolonged survival after primary infection.

Authors:  K G Mansfield; D Pauley; H L Young; A A Lackner
Journal:  J Infect Dis       Date:  1995-10       Impact factor: 5.226

View more
  44 in total

1.  Characterization of two divergent lineages of macaque rhadinoviruses related to Kaposi's sarcoma-associated herpesvirus.

Authors:  E R Schultz; G W Rankin; M P Blanc; B W Raden; C C Tsai; T M Rose
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 2.  Signaling activities of gammaherpesvirus membrane proteins.

Authors:  B Damania; J K Choi; J U Jung
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Activation of lymphocyte signaling by the R1 protein of rhesus monkey rhadinovirus.

Authors:  B Damania; M DeMaria; J U Jung; R C Desrosiers
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  Herpesvirus saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity.

Authors:  D Glykofrydes; H Niphuis; E M Kuhn; B Rosenwirth; J L Heeney; J Bruder; G Niedobitek; I Müller-Fleckenstein; B Fleckenstein; A Ensser
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Analysis of 4.3 kilobases of divergent locus B of macaque retroperitoneal fibromatosis-associated herpesvirus reveals a close similarity in gene sequence and genome organization to Kaposi's sarcoma-associated herpesvirus.

Authors:  Timothy M Rose; Jonathan T Ryan; Emily R Schultz; Brian W Raden; Che-Chung Tsai
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  Species specificity of macaque rhadinovirus glycoprotein B sequences.

Authors:  M R Auerbach; S C Czajak; W E Johnson; R C Desrosiers; L Alexander
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  A genetic system for rhesus monkey rhadinovirus: use of recombinant virus to quantitate antibody-mediated neutralization.

Authors:  John P Bilello; Jennifer S Morgan; Blossom Damania; Sabine M Lang; Ronald C Desrosiers
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 8.  Nonhuman primate models of human viral infections.

Authors:  Jacob D Estes; Scott W Wong; Jason M Brenchley
Journal:  Nat Rev Immunol       Date:  2018-06       Impact factor: 53.106

9.  Kinetics of expression of rhesus monkey rhadinovirus (RRV) and identification and characterization of a polycistronic transcript encoding the RRV Orf50/Rta, RRV R8, and R8.1 genes.

Authors:  Scott M DeWire; Michael A McVoy; Blossom Damania
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Infection and persistence of rhesus monkey rhadinovirus in immortalized B-cell lines.

Authors:  John P Bilello; Sabine M Lang; Fred Wang; Jon C Aster; Ronald C Desrosiers
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.